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Abstract 
Human leukaemia nhibitory factor (LIF) is a glycoprotein with a diverse range of activities on many cell types. A molecular model of LIF has 
been constructed based mainly on the structure of the related cytokine granulocyte colony-stimulating factor, and refined using simulated annealing 
and molecular dynamics in water. The model was stable during molecular dynamics refinement and is consistent with known stereochemical d ta 
on proteins. It has been assessed by comparison with ~H NMR data on the ionization behaviour of the six histidine residues inLIF, the imidazolium 
pKa values of which range from 3.6 to 7.4. These pKa values were assigned toindividual histidine residues from NMR studies on a series of His --* Ala 
mutants. The environments of the histidine residues inthe model account very well for their observed ionization behaviour. Furthermore, the model 
is consistent with mutagenesis tudies which have defined agroup of amino acid residues involved in receptor binding. 
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I. Introduction 
Leukaemia inhibitory factor (LIF) is one of a number 
of pleiotropic ytokines with overlapping functions [1,2]. 
It is active on a range of cell types including adipocytes, 
megakaryocytes, neuronal cells and osteoblasts [1]. On 
the basis of amino acid sequence, L IF  has been shown 
to be most closely related to oncostatin M (OSM) and 
ciliary neurotrophic factor (CNTF) and is part of a 
larger group of cytokines that includes interleukin-6 (IL- 
6) and granulocyte colony-stimulating factor (G-CSF) 
[3]. The high affinity L IF  receptor (LIFR) is composed 
of two subunits, an 0~-subunit that, by itself, binds L IF  
with low affinity and a fl-subunit, gpl30 [4]. The L IFR 
0~-subunit s also a component of the OSM and CNTF  
receptor complexes, while gpl30 is a component of the 
IL-6, IL-11, OSM and CNTF  receptor complexes [5]. 
These shared receptor subunits may explain some of the 
overlapping functions of this group of cytokines. 
The tertiary structures of several helical cytokines 
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have been determined by X-ray crystallography or NMR 
spectroscopy and have been reviewed by Sprang and 
Bazan [6]. They all show a similar up-up-down-down, 
left-handed, four helical bundle topology and have been 
classified into two structural groups [6]. The long-chain 
cytokines, which include G-CSF and growth hormone 
(GH), are larger and have 0~-helices that are longer on 
average and more tightly packed than in the short-chain 
group, which includes IL-4 and granulocyte-macrophage 
colony-stimulating factor (GM-CSF) [6]. These struc- 
tures provide a base from which models of related cytok- 
ines can be constructed. 
L IF  consists of 180 amino acids and has a molecular 
mass of about 20 kDa. Its tertiary structure has not been 
determined, although crystallisation of a human-like 
L IF  has been reported [7]. Determination of its structure 
in solution by NMR,  which requires that the protein be 
labelled with ~SN and ~3C [8], has not yet been achieved. 
We have, therefore, examined the structure of human 
LIF  (hLIF) by homology modelling and ~H NMR. A 
model was constructed based on the structure of G-CSF 
(the most closely related long-chain cytokine for which 
a 3D structure was available) and refined by simulated 
annealing and molecular dynamics in water. The model 
was then assessed experimentally by IH NMR and site- 
directed mutagenesis studies, which allowed the pK~ val- 
ues of the six histidine residues to be determined and 
assigned to specific residues in the protein. These data 
were then compared with the environments of the histid- 
ine residues in the model. The amino acid residues in 
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hLIF which have been shown to be involved in binding 
to the LIFR ct-subunit [9] were also examined for consis- 
tency with the model. 
2. Materials and methods 
2.1. Model building 
The cytokine four helical bundle structures are described by the 
helices of the bundle being designated A, B, C, D from the N- to the 
C-terminus, and the loops being designated by the helices they connect. 
The sequences of human, murine, rat, porcine and ovine LIF and 
murine and human G-CSF [10] were aligned using a multiple sequence 
alignment procedure [11,12] and the resulting alignment of hLIF and 
human G-CSF (hG-CSF), shown in Fig. 1, was examined for consis- 
tency with the heptad repeat motif observed in these cytokines l 13]. In 
this alignment the AB loop in LIF has an insertion of three amino acids 
relative to G-CSF, and LIF has an elongated N-terminal tail and a 
truncated C-terminal region. This alignment is identical to that of 
Bazan [3] for the A and D helices, the start of the AB loop and the end 
of the CD loop, but is different for the B and C helices. The alignment 
used here shows a better correspondence with the heptad repeat pattern 
for the B and C helices and a better distribution of gaps. The model of 
LIF was then created using the Homology module of Insight (Biosym 
Inc., San Diego, CA). The coordinates of the four bundle helices and 
the BC and CD loops were taken from hG-CSF and the N-terminal tail 
was built using the Homology module. As both human GH (hGH) [14] 
and hG-CSF [15] have a small helix in the N-terminal region of the AB 
loop, and hGH and hLIF have a broadly analogous disulfide bridge in 
this region, the helix in the AB loop of hG-CSF was copied to the LIF 
model. Because this helix is not seen in porcine GH [16] it has been 
suggested that in hGH it may form as a consequence of receptor binding 
[14] and that the similarity with hG-CSF may not be real [6]. Recently, 
however, it has been observed in a crystal structure of an hGH mutant 
that is not receptor bound [17]. The remainder ofthe AB loop was taken 
from a search of structures in the Protein Data Bank [18]. The second- 
ary structure prediction of Bazan [3], based on sequence alignments, 
defined the helices slightly differently from those in the structure of 
hG-CSF and in this work. Bazan excluded from the D helix the 'D1 
motif' (D~s4VFQKKKLG in hLIF), which is seen in LIF, OSM, CNTF 
and G-CSF. As this region is in the D helix in hG-CSF [15] it was 
included in the D helix of the LIF model. The region around Cys TM and 
Cys TM was not included in the C helix by Bazan [3]; in our case it was 
modelled from the C helix of hG-CSF but not subjected to helical 
restraints in the refinement. The A helix was modelled to be the length 
observed in hG-CSF [15] rather than the shorter length predicted by 
Bazan [3]. Finally, the model was surrounded by four layers of water 
molecules [19]. In simulations carried out in the absence of water the 
helical bundle was not stable, as polar side chains interacted with the 
helical bundle. 
2.2. Model refinement 
Refinement of the model was performed in several stages by a simu- 
lated annealing and molecular dynamics protocol using the X-PLOR 
program [20]. Simulated annealing from 600K to 300K was performed 
with 0.5-1 ps of molecular dynamics at each interval of 50K, followed 
by 5 ps of dynamics at 300K, in each case with a time step of 0.5 or 1 
fs. The three disulfide bridges in LIF [21] were defined and a CO~ to 
HNi+ 4 upper bound distance constraint of 2.2 A was specified for 
residues of the helix bundle, except for residues 131-135, which were 
excluded from helix C in order not to constrain the disulfide bridges 
involving Cys TM and Cys TM. For the first stage of refinement the C ° 
atoms of the bundle helices were held fixed and the loops and side 
chains were allowed to relax using the simulated annealing protocol. 
The next stage released the C a atoms but applied the upper bound 
constraint to the bundle helices and the simulated annealing protocol 
was repeated. This was followed by 100 ps of molecular dynamics with 
the helical constraints on and 64 ps of unrestrained dynamics at 300K. 
No restraints derived from NMR or biological data on LIF were used 
in the model building or the refinement. The stereochemical quality of 
the model was assessed and compared to a range of known protein 
crystal structures by using the PROCHECK suite of programs [22]. 
2.3. Protein preparation 
Histidine-to-alanine point mutations for His 16, His ~9, His 112, His t3s 
and His 141 in the hLIF amino acid sequence were constructed using a 
PCR-based technique and verified as described previously [9]. Human 
LIF and the His ~ Ala mutants were expressed in Escherichia coli 
NM522 as fusion proteins with glutathione S-transferase, and subse- 
quently cleaved with thrombin. Recombinant proteins were purified, 
characterised and assayed as described previously [9]. 
2.4. NMR 
Samples for NMR were prepared by dissolving lyophilized protein 
in either 100% 2H20 or 90% H2O110% 2H20. The pH was adjusted with 
2HC1 or NaO2H. The pH titration was performed in 100% 2H20 and 
pH values are reported as uncorrected meter eadings. Measurements 
were made at 26°C, a protein concentration f about 1 mM, and pH 
intervals of approximately 0.5 units in the pH range 1.8-8.4; the protein 
precipitated atpH 9. ~H NMR spectra were recorded on Bruker AMX- 
600 and AMX-500 spectrometers. Probe temperatures were maintained 
using a B-VT1000E control unit and a Haake cooling bath, and were 
calibrated using methanol and ethylene glycol [23]. Solvent suppression 
was performed by selective, low-power i radiation during the relaxation 
delay. Two-dimensional spectra were acquired using the time-propor- 
tional phase incrementation method [24] for quadrature detection i o~. 
A total correlation spectrum (TOCSY) [25] was collected at each pH 
using the DIPSI-2 [26] pulse sequence with a spin-lock period of 30 ms. 
Spectra were processed using UXNMR and AURELIA software 
(Bruker AG, Karlsruhe). 
2.5. pK  a values 
The pK, values of the six histidine residues were determined byfitting 
the chemical shifts of the C(2)H and C(4)H imidazole protons to the 
Henderson Hasselbalch equation for a single titrating roup or for a 
proton undergoing two independent ti rations [27]. As the pK~ values 
were not corrected for isotope ffects, values in H20 may be slightly 
lower [28]. The histidine residues were sequentially assigned by identify- 
ing the missing imidazole proton resonances in 1D and 2D TOCSY 
spectra of each of the five His ~ Ala mutants. Resonances from the 
sixth histidine residue were identified by inference. 
3. Results 
3.1. Model description 
The refined model of human LIF has the characteristic 
four 0~-helix bundle topology of the known helical cytok- 
ine structures (Fig. 2). Two small a-helices are present 
in the AB loop. The N-terminal helix in this loop is 
consistent with helices in hG-CSF [15] and hGH [14] but 
is more regular than the overlapping 3~0/~-helices in hG- 
CSF. This was modelled into the initial LIF structure as 
a helical region and, although changed, has remained a
helix throughout the refinement process. The small helix 
at the C-terminal end of the AB loop formed during the 
refinement process and is analogous to the second helix 
in the AB loop of hGH. Cys TM has remained in the 
C-terminus of the C helix but the region around Cys 134 
is not part of the helix. The two disulfide bridges these 
residues are involved in, Cys12-Cys TM and Cys~8-Cys TM, 
restrict he conformational space available to the region 
between Cys 12 and Cys ~s, causing a loop to form in the 
N-terminal tail of the model between Cys ~2 and Cys ~8. 
The beginning of the 'D1 motif' has lost its helical struc- 
ture but the rest has remained in the D helix. The three 
consecutive lysine residues in this region (158-160) sit 
above the helix bundle and would not have a destabili- 
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Fig. 1. The alignment of hLIF and hG-CSF showing the secondary 
structure summary of G-CSF [15] with the four helices of the helix 
bundle marked. The filled squares indicate identical residues (11% of 
the hLIF sequence) and the open circles conservative substitutions 
(22%). The sequences were aligned using the structural/chemical weight 
matrix of Bacon and Anderson [34], with a penalty of 9 for the creation 
of a gap and 1 per unit length of a gap, and unweighted leading and 
trailing gaps. The computer-generated lignment created two small 
gaps in the AB loop region of G-CSF, the first of which was merged 
with the second in order to model the AB loop helix from G-CSF. A 
one-residue gap between residues 2 and 3 in G-CSF was also removed. 
Secondary structure designations are: H, s-helix; G, 3,0-helix; T, turn; 
S, bend [35], with lower case letters indicating the boundaries of individ- 
ual secondary structure lements. The residues forming the heptad 
repeat pattern are underlined. The disulfide bonds in LIF are Cys t2- 
Cys TM, CyslS-Cyst31 and Cys6°-Cys 163 [21,33]. 
hydrophobic residues over the model is consistent with 
a four-helical bundle structure, with the hydrophobic 
core formed by residues in the heptad repeat pattern 
being protected from solvent and most of the polar resi- 
dues on the surface. 
3.3. Histidine pKa determination 
As one means of assessing the accuracy of the model 
we have determined the pKavalues of the six histidine 
residues in hLIF. TOCSY spectra were recorded over the 
pH range 1.8-8.4 in 2H20 to observe both the C(2)H and 
C(4)H resonances. The aromatic ring protons of the six 
Phe residues and six of the seven Tyr residues could also 
be identified in these spectra (Fig. 3). The pH titration 
data, fitted curves and pKa values for the C(2)H reso- 
nances are shown in Fig. 4. The His resonances were 
specifically assigned from spectra of the His ~ Ala mu- 
tants. The regions of His C(2)H to C(4)H cross-peaks in
TOCSY spectra of three of these mutants are shown in 
Fig. 3; in each case the location of the missing His spin 
system is clear. The specific activities in inducing the 
differentiation of murine M1 leukaemic olonies into 
macrophages [9] and the IDs0 values for inhibition of 
125I-labelled hLIF binding to the soluble murine LIF 
binding protein [9] of all five mutants were similar to 
those of hLIF within factors of 1.5 and 2, respectively 
(data not shown). 
The stability of hLIF over the pH range examined was 
sing influence on it. Other changes in the lengths of 
helices were restricted to extensions or contractions of 
only one residue at the termini. The backbone heavy 
atoms of the model after completion of 64 ps of unre- 
strained dynamics in water had RMSD values of 0.94 
and 0.46/k against structures at 42 and 60 ps, respec- 
tively; corresponding values for the backbone heavy 
atoms of the bundle helices were 0.62 and 0.38 A. 
3.2. Stereochemical quality 
The stereochemical quality of the model was assessed 
using X-PLOR [20] and the PROCHECK suite of pro- 
grams [22]. In terms of Ramachandran alysis, a~-angle 
planarity (RMSD 3.0°), bond lengths (RMSD 0.01 A), 
bond angles (RMSD 2.8 °) and C~-tetrahedral distortion 
(RMSD 1.6°), the model is equivalent to a protein struc- 
ture determined at approximately 2.5 A resolution when 
compared to the set of structures examined in PRO- 
CHECK. The helix packing angles are as follows: AC, 
24°; CB, 26°; BD, 36°; DA, 38 °. This places the model 
in the 'square' class of four-helical bundle proteins [29]. 
The LIF model has an RMSD of 2.7 ,~ from the hG-CSF 
crystal structure when superimposed over the C a atoms 
of the helix bundle. The distribution of hydrophilic and 
A 
Fig. 2. The model ofhLIF after efinement. The diagram was generated 
using MOLSCRIPT [36]. The B and C helices of the helical bundle are 
shaded ark grey and the two small helices in the AB loop light grey. 
The helices and loops are labelled with upper case letters and the N- 
and C-termini in lower case. 
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Fig. 3. Aromatic region of a TOCSY spectrum of hLIF in 2H20 at pH 
4.5 and 26°C. The locations of all aromatic amino acid spin systems 
except hat of one of the Tyr residues are shown. The lower panels how 
the region of His C(2)H to C(4)H cross-peaks inTOCSY spectra of the 
hLIF mutants H19A (pH 4.5), H138A (pH 3.4) and H141A (pH 3.4). 
Note that the different pH values for HI38A and H141A give rise to 
slight differences in chemical shifts and cross-peak intensities. Substitu- 
tion of either Hisl6 or Hisl9 by Ala caused a reduction in cross-peak 
intensity for the other, suggestive of an interaction between these resi- 
dues. All spectra were recorded at 600 MHz. 
demonstrated by the lack of change in the chemical shifts 
of the cross-peaks of other aromatic ring protons. Only 
one cross-peak (Tyr-c in Fig. 3) showed any significant 
movement with respect to pH. It appears to be monitor- 
ing the titration of a carboxyl group with a pKa of 3.4. 
4. Discussion 
The model of hLIF based on hG-CSF proved to be 
stable during the simulated annealing and molecular dy- 
namics refinement process and is consistent with known 
stereochemical data on proteins. It also accounts very 
well for the pKa values of the six His residues, determined 
from the NMR data and identified by the His---> Ala 
mutants. The locations of the His residues in the model, 
and of nearby residues thought o influence their pKa 
values, are shown in Fig. 5. His 16 and His w have slightly 
lowered pK, values compared with those of 6.5-6.6 
found in denatured proteins [30], indicating a slight des- 
tabilisation of their protonated forms. In the model the 
loop formed in the N-terminal tail brings His ]6 into line 
with the axis of the A helix and Arg ~5 close to His 16 and 
His 19 (which is at the N-terminus of helix A). The influ- 
ence of the positive charges of the helix dipole and the 
arginine side chain would be expected to lower the pK, 
of these histidine residues [28,30], as was observed. His 71 
shows two independent ti rations, the first reflecting a
carboxyl titration (pK,2.6) and the second representing 
the imidazolium pKa, which is slightly elevated at 7.4. 
This is also consistent with the model, where formation 
of the C-terminal helix in the AB loop brings His 7] into 
close proximity to Glu 76. The negatively charged envi- 
ronment could stabilize the protonated form of His 7j, 
thus elevating its pK,. His 112 has a significantly owered 
pKa value, suggesting that its imidazolium form is greatly 
destabilised. This is probably due to the cluster of posi- 
tively charged lysine residues (102, 114, 153, 158, 159) 
around His ll2 in the model, two of which come from the 
D1 motif [3]. His H2 has been shown to be involved in the 
binding of hLIF to its receptor ~-subunit [9] and its low 
pKa may be important for receptor binding. Finally, 
His 138 and His 14~ show essentially normal pKa values, 
indicating that they are not affected by nearby charged 
groups and are probably exposed to solvent. In the 
model they are located in the CD loop but His 138 is close 
to Lys 136 and His TM to Asp 143. The fact that these nearby 
charged sidechains do not significantly affect the pK, 
values of the histidines may reflect the possibility that 
this region of the structure is flexible in solution. In the 
X-ray structures of GH [14], IL-2 [31] and G-CSF [15,32] 
part of the CD loop cannot be seen in the electron den- 
sity, suggesting that this is a mobile region in these mol- 
ecules. Analysis of the last 22 ps of the dynamics trajec- 
tory of the hLIF model in water indicates that the 
N-terminus and the N-terminal region of the CD loop 
are amongst the most variable parts of the structure. 
8.s ...........  Hisi38 ................. 
. . . . . . . . . . . . . . . . . . . . . . .  
7.S  I I I I I I I 
2 3 4 5 6 7 8 9 
pH 
Fig. 4. pH titration curves for the six His residues of hLIF in 2H20 at 
26°C. The pK a values and, in parentheses, the C(2)H chemical shifts in 
ppm at the acidic and basic extremes, respectively, of the imidazolium 
titration were: His 16, 5.9 (8.64, 7.72); His 19, 5.7 (8.63, 7.64); His 7t, 7.4 
(8.34, 7.46); His ~'2, 3.6 (8.65, 7.64); His ~8, 6.8 (8.60, 7.64); His TM, 6.4 
(8.66, 7.69). 
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Fig. 5. Stereo views, generated using MOLSCRIPT [36], of the model 
of hLIF showing the His residues (dark shading) and other residues 
which may influence the His pK, values (light shading). For clarity, the 
sidechain of Glu 76 is not labelled. This view is related to that in Fig. 2 
by an approximately 180 ° rotation around the vertical axis. 
Asparagines 9, 34, 63, 73, 96 and 116 have been iden- 
tified as N-glycosylation sites in hLIF [33]. These resi- 
dues are exposed in the model except for Asn 9 and msn 96. 
Asn 9 is in the long N-terminal tail preceding the first 
disulfide bridge, a region which is expected to be mobile 
and thus unreliable in the model, msn 96 is partially oc- 
cluded by Tyr 146 in the CD loop, which, as noted above, 
is also likely to be mobile. 
The two small helices in the AB loop of the hLIF 
model may be a conserved feature of the long-chain 
group of cytokines as they were either preserved or 
formed in the refinement process. Furthermore, forma- 
tion of the more C-terminal of these helices allows the 
double titration of His 7~ to be explained. These helices 
are also present in the soluble form of an hGH mutant 
[17]. In hGH they are involved in receptor binding [14] 
and, if this is indeed a conserved feature, they may have 
similar functions in G-CSF and LIF. A study of mouse- 
human chimeras of LIF [9] identified His H2, Ser 113, and 
some residues of the BC and CD loops as being involved 
in the binding of hLIF to its receptor. It is likely that 
residues in the D 1 motif are involved in receptor binding 
as they form a contiguous urface on the model with 
His 112 and Ser 113 and are involved in the low pK a of 
His t 12. If the D 1 motif is involved in receptor binding, its 
conservation i G-CSF, CNTF and OSM would be con- 
sistent with a similar role in those molecules. 
The NMR experiments described in this paper provide 
information on the pH stability and ionization behaviour 
of hLIF. Although His 71 and His ll/participate in inter- 
actions which perturb their pKa values significantly, in 
the case of His ~12 by 3 pH units from the expected value, 
the overall structure of hLIF as monitored by 2D ~H 
NMR is stable over the pH range 1.8-8.4. This implies 
that the electrostatic interactions involving these His res- 
idues, while important locally, do not play a major role 
in stablizing the native structure. 
In this study we have described a model of LIF which 
is supported by the histidine pK a values observed by ~H 
NMR and is consistent with the known N-glycosylation 
sites and receptor binding site data. The atomic coordi- 
nates of the model are available on request. 
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